Feedback / Questions
BREN-02 - BrainEver
https://www.businesswire.com/news/home/20201123005830/en/BrainEver-Receives-FDA-Orphan-Drug-Designation-for-BREN-02-human-recombinant-Engrailed-1-for-the-Treatment-of-Amyotrophic-Lateral-Sclerosis-ALS
 
Nov 23, 2020
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious